ResMed
A global leader in digital health and connected medical devices, plus software solutions that support out-of-hospital care providers.
Launch date
Employees
Market cap
€33.5b
Enterprise valuation
€34.1b (Public information from Sep 2024)
Share price
$238.03 RMD
San Diego California (HQ)
Financials
Estimates*
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 3.2b | 3.6b | 4.2b | 4.7b | 5.0b | 5.4b | 5.7b |
| % growth | 8 % | 12 % | 18 % | 11 % | 8 % | 7 % | 6 % |
| EBITDA | 1.1b | 1.2b | 1.3b | 1.6b | 1.8b | 1.9b | 2.1b |
| % EBITDA margin | 35 % | 33 % | 32 % | 34 % | 35 % | 36 % | 36 % |
| Profit | 475m | 779m | 898m | 1.0b | 1.3b | 1.4b | 1.6b |
| % profit margin | 15 % | 22 % | 21 % | 22 % | 26 % | 27 % | 27 % |
| EV / revenue | 11.3x | 8.7x | 7.9x | 6.1x | 7.1x | 6.4x | 5.9x |
| EV / EBITDA | 32.6x | 26.1x | 24.9x | 17.9x | 20.0x | 17.9x | 16.3x |
| R&D budget | 225m | 254m | 288m | 308m | - | - | - |
| R&D % of revenue | 7 % | 7 % | 7 % | 7 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
$1.1m | Seed | ||
* | N/A | $500m | Post IPO Debt |
| Total Funding | €1.0m | ||
Recent News about ResMed
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by ResMed
Edit
ACQUISITION by ResMed Jul 2011
exited
ACQUISITION by ResMed Feb 2016
ACQUISITION by ResMed Dec 2018
ACQUISITION by ResMed Feb 2016
ACQUISITION by ResMed Jun 2022
ACQUISITION by ResMed Nov 2015
ACQUISITION by ResMed Feb 2015
ACQUISITION by ResMed Jul 2023
ACQUISITION by ResMed Oct 2015